Document:

Employment Agreement dated as of April 2, 2007

 Exhibit 10.28 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (this “Agreement”), dated as of
April 2, 2007, is made by and between Keystone Automotive Holdings, Inc., a Delaware corporation (the “Company”), and Donald T. Grimes (“Executive”). 
 WHEREAS, the Company has offered, and Executive has accepted, a position of employment with the Company as the Company’s chief financial officer and
executive vice president. 
 NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 1. Definitions.
In this Agreement: 
 “Base Salary” has the meaning given to that term in Section 3(a). 
 “Benefits” means, collectively, all of the employee benefit programs, including, without limitation, medical and dental plans and
retirement plans, for which senior executive employees of the Company and its Subsidiaries are generally eligible. 
 “Board” means the Board of Directors of the Company. 
 “Cause” means Executive (i) commits,
or is charged with, a felony or other crime involving moral turpitude; (ii) engages in willful misconduct or fraud with respect to the Company or any of its Subsidiaries or any of their customers or suppliers or an intentional act of dishonesty
or disloyalty in the course of his employment; (iii) engages in the abuse of alcohol or illegal drugs causing the Company or any of its Subsidiaries material disrepute or economic harm or materially adversely affecting Executive’s ability
to perform his duties, responsibilities and functions hereunder; (iv) refuses to perform his material obligations under this Agreement (except in connection with a Disability) as reasonably directed by the Board, which failure is not cured
within 15 days after written notice thereof to Executive; (v) misappropriates one or more of the Company’s assets or business opportunities; or (vi) breaches Section 5, 6 or 7 hereof which breach, if capable
of being cured, is not cured within 10 days after written notice thereof has been delivered to Executive. 
 “Disability”
means Executive’s inability to perform the essential duties, responsibilities and functions of his position with the Company and its Subsidiaries for a continuous period of 180 days as a result of any mental or physical disability or
incapacity, as determined under the definition of disability in the Company’s long-term disability plan so as to qualify Executive for benefits under the terms of that plan or as determined by an independent physician to the extent no such plan
is then in effect. Executive shall cooperate in all respects with the Company if a question arises as to whether he has become disabled (including, without limitation, submitting to an examination by a medical doctor or other health care specialists
selected by the Company and authorizing such medical doctor or such other health care specialist to discuss Executive’s condition with the Company). 

 “Employment Period” means the period commencing on the date hereof and ending on the
Expiration Date or such earlier date as contemplated in the proviso to Section 4(a). 
 “Expiration Date” means
the third anniversary of the date hereof; provided, that if a written notice is not given by the Company or Executive at least 90 days prior to such anniversary (or any subsequent anniversary if this Agreement is extended) stating that such
party is electing to terminate the Employment Period, then the Expiration Date will automatically be extended to the next anniversary of the date hereof. 
 “Expiration Year” means the calendar year in which the Employment Period expires. 
 “Good Reason” means: (i) Executive’s compensation is reduced in a manner not in accordance with the provisions for any such reduction provided by this Agreement; (ii) Executive’s duties or authority are
changed, without his permission, in a manner materially inconsistent with his role as chief financial officer and executive vice president or they are adversely changed or reduced; or (iii) there is otherwise a material breach of this Agreement
by the Company. 
 “Non-Compete Period” means the period commencing on the date hereof and ending 12 months after
Executive’s termination of employment. 
 “Termination Year” means the calendar year in which the Employment Period is
terminated. 
 “Subsidiaries” means any corporation or other entity of which the securities or other ownership interests
having the voting power to elect a majority of the board of directors or other governing body are, at the time of determination, owned by the Company, directly or through one of more Subsidiaries. 
 2. Employment, Position and Duties. 
 (a) The Company shall employ Executive and Executive hereby accepts employment with the Company, upon the terms and conditions set forth in this Agreement, for the Employment Period. 
 (b) During the Employment Period, Executive shall serve as the chief financial officer and executive vice president of the Company and shall perform the
normal duties, responsibilities and functions of the chief financial officer and executive vice president of a company of a similar size and type and shall have such power and authority as shall reasonably be required to enable him to perform his
duties hereunder, subject to the power and authority of the Board to expand or limit such duties, responsibilities, functions, power and authority and to overrule actions of officers of the Company in a manner consistent with the traditional
responsibilities of such office. 
  

 2 

 (c) During the Employment Period, Executive shall (i) render such administrative, financial and
other executive and managerial services to the Company and its Subsidiaries which are consistent with Executive’s position as the Board may from time to time direct, (ii) report to the Company’s chief executive officer and the Board,
and devote his best efforts and his full business time and attention (except for permitted vacation periods and reasonable periods of illness or other incapacity and except that Executive may, with the consent of the Board (which consent shall not
be unreasonably withheld) serve as a director of an unrelated Person that is not engaged in a Competing Business (as defined below)) to the business and affairs of the Company and its Subsidiaries and (iii) submit to the Board all business,
commercial and investment opportunities presented to Executive or of which Executive becomes aware which relate to the business of the Company and its subsidiaries and unless approved by the Board in writing, Executive shall not pursue, directly or
indirectly, any such opportunities on Executive’s own behalf. Executive shall perform his duties, responsibilities and functions to the Company and its Subsidiaries hereunder to the best of his abilities in a diligent, trustworthy and
professional manner. 
 3. Compensation and Benefits. 
 (a) During the Employment Period, Executive’s base salary shall be a minimum of $325,000 per annum (as increased or decreased in accordance with this Agreement from time to time, the “Base
Salary”), which salary shall be payable by the Company in regular installments in accordance with the Company’s general payroll practices in effect from time to time. Executive’s Base Salary will be subject to review and increase
or decrease (but not below the Base Salary in effect on the date of this Agreement) by the Board on or about January 1 of each fiscal year during the Employment Period. In addition, during the Employment Period, Executive shall be entitled
(i) to participate in all of the Benefits, (ii) an automobile allowance of $150.00 per week, and (iii) the home sale support package described in the offer letter dated January 12, 2007 by and between Keystone Automotive
Operations, Inc. and Executive (the “Offer Letter”). 
 (b) Executive shall be entitled to fifteen (15) days of paid
vacation each calendar year, which will accrue in accordance with the Company’s vacation policies in effect from time to time. Any vacation not taken in any year may not be carried forward to any subsequent calendar year and no compensation
shall be payable in lieu thereof. 
 (c) During the Employment Period, the Company shall reimburse Executive for all reasonable business
expenses incurred by him in the course of performing his duties, responsibilities and functions under this Agreement which are consistent with the Company’s policies in effect from time to time with respect to travel, entertainment and other
business expenses, subject to the Company’s requirements with respect to reporting and documentation of such expenses. 
 (d) In
addition to the Base Salary, following the end of each fiscal year during the Employment Period, the Board shall award a bonus to Executive in an amount to be determined by the Board (with a target of 70% of Executive’s Base Salary in effect at
the end of such fiscal year) based upon Executive’s performance and the Company’s achievement of operating targets established by the Board (or any compensation committee thereof) in consultation with Executive at the beginning of such
fiscal year. 
  

 3 

 (e) Executive will be indemnified and defended for acts performed (or omissions made) in his capacity as
an officer or director of the Company to the fullest extent specified in the Company’s certificate of incorporation and bylaws and as permitted under Delaware law. 
 4. Termination and Payment Terms. 
 (a) The Employment Period shall end on the Expiration Date;
provided, that (i) the Employment Period shall terminate prior to such date immediately upon Executive’s resignation, death or Disability and (ii) the Employment Period may be terminated by resolution of the Board, with or
without Cause at any time prior to such date. Except as otherwise provided herein, any termination of the Employment Period by the Company shall be effective as specified in a written notice from the Company to Executive. 
 (b) If the Employment Period is terminated prior to the Expiration Date: 
 (i) (A) by resolution of the Board (other than for Cause) or by Executive resigning for Good Reason, (B) as a result of Executive’s death or Disability, or (C) if the Employment Period expires on the
Expiration Date, Executive shall be entitled to receive (1) all previously earned and accrued but unpaid Base Salary and vacation and unpaid business expenses up to the date of such termination or the Expiration Date, as applicable,
(2) any bonus (if any) earned by Executive for the fiscal year prior to the Termination Year or the Expiration Year, as applicable, but then unpaid, (3) the pro rata portion of Executive’s target bonus during the Termination Year or
the Expiration Year, as applicable, to the extent targets thereunder are achieved for such year after such termination or expiration, pro rated based on the number of days of the Termination Year or the Expiration Year, as applicable, prior to the
date of termination or the Expiration Date, as applicable, which payment shall be made when the bonus payments for such Termination Year or the Expiration Year, as applicable, are otherwise due; (4) severance pay in the full amount of Base
Salary at the time of termination or expiration from the date of termination or the Expiration Date, as applicable, through the period ending on the first anniversary of the date of termination or the Expiration Date, as applicable, payable by the
Company in regular installments in accordance with the Company’s general payroll practices in effect from time to time, and (5) full continuation of Executive’s health, disability and life insurance Benefits during the one year
severance period (to the extent any of those Benefits cannot be provided by Company during the one year severance period, the Company will provide Executive with a sum of money calculated to permit Executive to obtain the same benefits individually,
grossed up for tax purposes so that Executive remains whole); or 
 (ii) for any other reason, including as a result of Executive’s
voluntary resignation for other than Good Reason or by resolution of the Board for Cause, Executive’s sole entitlement shall be to receive all previously earned and accrued but unpaid Base Salary, vacation and unpaid business expenses up to the
date of such termination or expiration and Executive shall not be entitled to any further Base Salary, bonus payments or Benefits for that year or any future year, except as required by law, or to any other severance compensation of any kind.

  

 4 

 (c) Executive agrees that: (i) Executive shall be entitled to the payments and services provided
for in Sections 4(b)(i)(3), 4(b)(i)(4), 4(b)(i)(5) and 4(b)(i)(6), if any, if and only if Executive has executed and delivered the Release attached hereto as Exhibit A (the “Release”) and seven (7) days have elapsed
since such execution without any revocation thereof by Executive and Executive has not breached as of the date of termination of the Employment Period the provisions of Sections 5, 6 and 7 hereof and does not breach such
sections or such covenants or any representation or warranty or covenant in the Release at any time during the period for which such payments or services are to be made; and (ii) the Company’s obligation to make such payments and services
will terminate upon the occurrence of any such breach during such period. 
 (d) Except as stated above, any payments pursuant to
Section 4(b) shall be paid by the Company in regular installments in accordance with the Company’s general payroll practices, and following such payments the Company shall have no further obligation to Executive pursuant to this
Section 4 except as provided by law. All amounts payable to Executive as compensation hereunder shall be subject to all customary withholding, payroll and other taxes. The Company shall be entitled to deduct or withhold from any amounts
payable to Executive any federal, state, local or foreign withholding taxes, excise tax, or employment taxes imposed with respect to Executive’s compensation or other payments or Executive’s ownership interest in the Company (including,
without limitation, wages, bonuses, dividends, the receipt or exercise of equity options and/or the receipt or vesting of restricted equity). 
 (e) Executive hereby agrees that except as expressly provided herein, no severance compensation of any kind, nature or amount shall be payable to Executive and except as expressly provided herein, Executive hereby irrevocably waives any
claim for severance compensation. 
 (f) Except as provided in Sections 4(b)(i) and 4(b)(ii) above, all of Executive’s
rights to Benefits hereunder (if any) shall cease upon the termination or expiration of the Employment Period. 
 5. Confidential
Information. 
 (a) Executive acknowledges that the information, observations and data (including trade secrets) that will be obtained by
him while employed by the Company concerning the business or affairs of the Company and its Subsidiaries (“Confidential Information”) are the property of the Company or such Subsidiary. Therefore, Executive agrees that, except as
required by law or court order, including, but not limited to, depositions, interrogatories, court testimony, and the like, he shall not disclose to any unauthorized person or use for his own purposes any Confidential Information without the prior
written consent of the Board, unless and to the extent that the Confidential Information becomes generally known to and available for use by the public other than as a result of Executive’s acts or omissions. Executive shall deliver to the
Company at the termination or expiration of the Employment Period, or at any other time the Company may request, all memoranda, notes, plans, records, 

  

 5 

 
reports, computer tapes, printouts and software and other documents and data (and copies thereof) embodying or relating to the Confidential Information, Work
Product (as defined below) or the business of the Company and its Subsidiaries which he may then possess or have under his control. 
 (b)
Executive shall be prohibited from using or disclosing any confidential information or trade secrets that Executive may have learned through any prior employment. If at any time during this employment with the Company or any Subsidiary, Executive
believes he is being asked to engage in work that will, or will be likely to, jeopardize any confidentiality or other obligations Executive may have to former employers, Executive shall immediately advise the Board so that Executive’s duties
can be modified appropriately. 
 (c) Executive represents and warrants to the Company that Executive took nothing with him which belonged
to any former employer when Executive left his prior position and that Executive has nothing that contains any information which belongs to any former employer. If at any time Executive discovers this is incorrect, Executive shall promptly return
any such materials to Executive’s former employer. The Company does not want any such materials, and Executive shall not be permitted to use or refer to any such materials in the performance of Executive’s duties hereunder. 
 6. Intellectual Property, Inventions and Patents. Executive acknowledges that all discoveries, concepts, ideas, inventions, innovations,
improvements, developments, methods, designs, analyses, drawings, reports, patent applications, copyrightable work and mask work (whether or not including any confidential information) and all registrations or applications related thereto, all other
proprietary information and all similar or related information (whether or not patentable) which relate to the Company’s or any of its Subsidiaries’ actual or anticipated business, research and development or existing or future products or
services and which are conceived, developed or made by Executive (whether above or jointly with others) while employed by the Company (“Work Product”), belong to the Company or such Subsidiary. Executive shall promptly disclose such
Work Product to the Board and, at the Company’s expense, perform all actions reasonably requested by the Board (whether during or after the Employment Period) to establish and confirm such ownership (including, without limitation, assignments,
consents, powers of attorney and other instruments). 
 7. Non-Compete, Non-Solicitation. 
 (a) In further consideration of the compensation to be paid to Executive hereunder, Executive acknowledges that during the course of his employment with
the Company he shall become familiar with the Company’s and its Subsidiaries’ trade secrets and with other Confidential Information concerning the Company and its Subsidiaries (and their respective predecessor companies) and that his
services have been and shall be of special, unique and extraordinary value to the Company and its Subsidiaries, and therefore, Executive agrees that, during the Employment Period and thereafter until the end of the Noncompete Period, he shall not
directly or indirectly own any interest in, manage, control, participate in, consult with, render services for, or in any manner engage in any Competing Business within any geographical area in which the Company or its Subsidiaries engage or plan to
engage in such businesses. Nothing herein shall prohibit Executive from being a passive owner of not more than 2% of the 

  

 6 

 
outstanding stock of any class of a corporation which is publicly traded, so long as Executive has no active participation in the business of such
corporation. For purposes of this paragraph, “Competing Business” means any business that is substantially the same as, or competitive with, the business of the Company, including, without limitation, any business involving the
distribution or marketing of after market specialty automobile parts. 
 (b) During the Noncompete Period, Executive shall not directly or
indirectly through another person or entity (i) induce or attempt to induce any executive of the Company or any Subsidiary to leave the employ of the Company or such Subsidiary, or in any way interfere with the relationship between the Company
or any Subsidiary and any executive thereof, (ii) hire any person who was an executive of the Company or any Subsidiary at any time within the one year period before Employee’s termination from employment or (iii) induce or attempt to
induce any customer, supplier, licensee, licensor, franchisee or other business relation of the Company or any Subsidiary to cease doing business with the Company or such Subsidiary, or in any way interfere with the relationship between any such
customer, supplier, licensee or business relation and the Company or any Subsidiary. 
 (c) If, at the time of enforcement of this
Section 7, a court shall hold that the duration, scope or area restrictions stated herein are unreasonable under circumstances then existing, the parties agree that the maximum duration, scope or area reasonable under such circumstances
shall be substituted for the stated duration, scope or area and that the court shall be allowed to revise the restrictions contained herein to cover the maximum period, scope and area permitted by law. Executive acknowledges that the restrictions
contained in this Section 7 are reasonable and that he has reviewed the provisions of this Agreement with his legal counsel. 
 (d) In the event of the breach or a threatened breach by Executive of any of the provisions of this Section 7, the Company would suffer irreparable harm, and in addition and supplementary to other rights and remedies existing in
its favor, the Company shall be entitled to specific performance and/or injunctive or other equitable relief from a court of competent jurisdiction in order to enforce or prevent any violations of the provisions hereof (without posting a bond or
other security). 
 8. Company’s Obligations. Notwithstanding anything in this Agreement to the contrary, the Company shall have
the right to satisfy any obligation owing to Executive hereunder (including, without limitation, any payment obligation) by causing Keystone Automotive Operations, Inc. or any other Subsidiary of the Company to satisfy such obligation on behalf of
the Company. In the event the Company fails to, or elects not to, satisfy any obligation owing hereunder to Executive, Executive shall have the right to seek satisfaction of such right against Keystone Automotive Operations, Inc. or any other
Subsidiary of the Company. 
 9. Executive’s Representations. Executive hereby represents and warrants to the Company that
(i) the execution, delivery and performance of this Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree to which Executive is a party
or by which he is bound, (ii) Executive is not a party to or bound by any employment agreement, noncompete agreement or confidentiality agreement with any other person or entity and (iii) upon the execution and 

  

 7 

 
delivery of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in accordance with its terms.
EXECUTIVE HEREBY ACKNOWLEDGES AND REPRESENTS THAT HE HAS CONSULTED WITH INDEPENDENT LEGAL COUNSEL REGARDING HIS RIGHTS AND OBLIGATIONS UNDER THIS AGREEMENT AND THE TERMS OF THE RELEASE ATTACHED HERETO AS EXHIBIT A AND THAT HE FULLY
UNDERSTANDS THE TERMS AND CONDITIONS CONTAINED HEREIN AND THEREIN. 
 10. Survival. This Agreement survives and continues in full
force in accordance with its terms notwithstanding the expiration or termination of the Employment Period. 
 11. Notices. Any notice
provided for in this Agreement shall be in writing and shall be either personally delivered, sent by reputable overnight courier service or mailed by first class mail, return receipt requested, to the recipient at the address below indicated:

 Notice to Executive: 
 Donald T. Grimes 
 195 Ice Lake Drive 
 Mountain Top, PA 18707 
 Notice to the Company: 
 Keystone Automotive Holdings, Inc. 
 44
Tunkhannock Avenue 
 Exeter, PA 18643 
 Attention: Board of Directors 
 Fax:          (570) 655-8203 
 With copies (which shall not constitute notice to the Company): 
 Bain Capital Partners, LLC 
 745 Fifth Avenue 
 New York, NY 10151 
 Attention: Stephen Zide

 Fax:          (212) 421-2225 
 Kirkland& Ellis, LLP 
 153 East 53rd
Street 
 New York, NY 10022 
 Attention: Eunu Chun 
 Fax:          (212) 446-4900 
 or such other address or to the attention of such other person as the recipient party shall have specified by prior written notice to the sending party. Any notice under
this Agreement shall be deemed to have been given when so delivered, one business day after being so sent or five business days after being so mailed. 
  

 8 

 12. Complete Agreement. This Agreement and the Equity Documents (as defined below) embody the
complete agreement and understanding between the parties hereto and supersede and preempt any prior understandings, agreements (including, without limitation, the Offer Letter, except as set forth in clause (iii) of Section 3(a) above), or
representations by or among the parties hereto, written or oral, which may have related to the subject matter hereof in any way. For purposes of this Agreement, “Equity Documents” means, collectively, upon the granting to Executive
of stock options in the Company as contemplated by the letter agreement referenced above, (i) Company’s 2003 Executive Stock Option Plan, (ii) any Option Agreement, executed by and between the Company and Executive, and if options are
so granted, (iii) the Stockholders Agreement, dated October 30, 2003, by and among the Company and the Company’s stockholders from time to time parties thereto and (iv) the Registration Rights Agreement, dated October 30,
2003, by and among the Company and the Company’s stockholders from time to time parties thereto, in each case, as such document may be amended, restated or otherwise modified from time to time in accordance with its terms. 
 13. Counterparts. This Agreement may be executed in separate counterparts, each of which is deemed to be an original and all of which taken
together constitute one and the same agreement. 
 14. Successors and Assigns. This Agreement is intended to bind and inure to the
benefit of and be enforceable by Executive, the Company and their respective heirs, successors and assigns; provided, that the services provided by Executive under this Agreement are of a personal nature and rights and obligations of
Executive under this Agreement shall not be assignable. 
 15. Choice of Law; Jurisdiction. ALL ISSUES AND QUESTIONS CONCERNING THE
CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT AND THE EXHIBITS AND SCHEDULES HERETO SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR
CONFLICT OF LAW RULES OR PROVISIONS, WHETHER OF THE STATE OF DELAWARE OR OTHERWISE, AND THE PARTIES HERETO HEREBY IRREVOCABLY SUBMIT TO THE JURISDICTION OF THE COURTS OF THE STATE OF DELAWARE. 
 16. Amendment and Waiver. The provisions of this Agreement may be amended or waived only with the prior written consent of the Company (as
approved by the Board) and Executive, and no course of conduct or course of dealing or failure or delay by any party hereto in enforcing or exercising any of the provisions of this Agreement (including, without limitation, the Company’s right
to terminate the Employment Period for Cause) shall affect the validity, binding effect or enforceability of this Agreement or be deemed to be an implied waiver of any provision of this Agreement. 
 17. Key Man Life Insurance. The Company may apply for and obtain and maintain a key man life insurance policy in the name of Executive together
with other executives of the Company in an amount deemed sufficient by the Board, the beneficiary of which shall be the Company. Executive shall submit to physical examinations and answer reasonable questions in connection with the application and,
if obtained, the maintenance of, as may be required, such insurance policy. 
  

 9 

 18. Executive’s Cooperation. During the Employment Period and thereafter, Executive shall
cooperate with the Company and its Subsidiaries in any internal investigation or administrative, regulatory or judicial proceeding as reasonably requested by the Company (including, without limitation, Executive being available to the Company upon
reasonable notice for interviews and factual investigations, appearing at the Company’s request to give testimony without requiring service of a subpoena or other legal process, volunteering to the Company all pertinent information and turning
over to the Company all relevant documents which are or may come into Executive’s possession, all at times and on schedules that are reasonably consistent with Executive’s other permitted activities and commitments). In the event the
Company requires Executive’s cooperation in accordance with this section after the termination of the Employment Period, the Company shall reimburse Executive for all of his reasonable costs and expenses incurred, in connection therewith, plus
pay Executive a reasonable amount per day for his time spent. 
 * * * * * 
  

 10 

 IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the date first
written above. 
  

			
	KEYSTONE AUTOMOTIVE HOLDINGS, INC.
		
	By:	 	 /s/ Edward H. Orzetti

	Name:	 	
	Title:	 	
	
	 /s/ Donald T. Grimes

	DONALD T. GRIMES

 EXHIBIT A 
 Form of Release 
 THIS RELEASE (this
“Release”) is made as of this      day of                     , 20    ,
by and between Keystone Automotive Operations, Inc., a Delaware corporation (the “Company”), and Donald T. Grimes (“Executive”). 
 PRELIMINARY RECITALS 
 A. Executive’s employment with the Company has terminated. 
 B. Executive and the Company are parties to an Employment Agreement, dated as of
[                    ], 2007 (the “Agreement”). 
 AGREEMENT 
 In consideration of the payments due Executive under the Agreement,
and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 1. Executive, intending to be legally bound, does hereby, on behalf of himself and his agents, representatives, attorneys, assigns, heirs, executors and administrators (collectively, the “Executive Parties”) REMISE, RELEASE
AND FOREVER DISCHARGE the Company, its affiliates, subsidiaries, parents, joint ventures, and its and their officers, directors, shareholders, members, managers and employees, and its and their respective successors and assigns, heirs, executors,
and administrators (collectively, the “Company Parties”) from all causes of action, suits, debts, claims and demands whatsoever in law or in equity, which Executive or any of the Executive Parties ever had, now has, or hereafter may
have, by reason of any matter, cause or thing whatsoever, from the beginning of Executive’s initial dealings with the Company to the date of this Release, and particularly, but without limitation of the foregoing general terms, any claims
arising from or relating in any way to Executive’s employment relationship with Company, the terms and conditions of that employment relationship, and the termination of that employment relationship, including, but not limited to, any claims
arising under the Age Discrimination in Employment Act, as amended, 29 U.S.C. § 621 et seq. (the “ADEA”), Title VII of The Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000e et seq., the Civil Rights Act of 1966, 42
U.S.C. §1981, the Civil Rights Act of 1991, Pub. L. No. 102-166, the Americans with Disabilities Act, 42 U.S.C. §12101 et seq., the Age Discrimination in Employment Act, as amended, 29 U.S.C. §621 et seq., the Fair Labor
Standards Act, 29 U.S.C. §201 et seq., the National Labor Relations Act, 29 U.S.C. §151 et seq., and any other claims under any federal, state or local common law, statutory, or regulatory provision, now or hereafter recognized, but not
including such claims to payments and other rights provided Executive under the Agreement. This Release is effective without regard to the legal nature of the claims raised and without regard to whether any such claims are based upon tort, equity,
implied or express contract or discrimination of any sort. Except as specifically provided herein, it is expressly understood and agreed that this Release shall operate as a clear and unequivocal waiver by Executive of any claim for accrued or
unpaid wages, benefits or any other type of payment. 
  

 1 

 2. Executive expressly waives all rights afforded by any statute which limits the effect of a release
with respect to unknown claims. Executive understands the significance of his release of unknown claims and his waiver of statutory protection against a release of unknown claims. 
 3. Executive agrees that he will not be entitled to or accept any benefit from any claim or proceeding within the scope of this Release that is filed or
instigated by him or on his behalf with any agency, court or other government entity. 
 4. Executive further agrees and recognizes that he
has permanently and irrevocably severed his employment relationship with the Company, effective as of the date hereof, that he shall not seek employment with the Company or any affiliated entity at any time in the future, and that the Company has no
obligation to employ him in the future. 
 5. The parties agree and acknowledge that the Agreement, and the settlement and termination of any
asserted or unasserted claims against the Company and the Company Parties pursuant to this Release, are not and shall not be construed to be an admission of any violation of any federal, state or local statute or regulation, or of any duty owed by
the Company or any of the Company Parties to Executive. 
 6. Executive certifies and acknowledges as follows: 
 (a) That he has read the terms of this Release, and that he understands its terms and effects, including the fact that he has agreed to
RELEASE AND FOREVER DISCHARGE the Company and all Company Parties from any legal action or other liability of any type related in any way to the matters released pursuant to this Release other than as provided in the Agreement and in this Release;

 (b) That he has signed this Release voluntarily and knowingly in exchange for the consideration described herein, which he
acknowledges is adequate and satisfactory to him and which he acknowledges is in addition to any other benefits to which he is otherwise entitled; 
 (c) That he has been and is hereby advised in writing to consult with an attorney prior to signing this Release; 
 (d) That he does not waive rights or claims that may arise after the date this Release is executed or those claims arising under the Agreement with respect to payments and other rights due Executive on the date of, or
during the period following, the termination of his Employment; 
 (e) That the Company has provided him with adequate
opportunity, including a period of twenty-one (21) days from the initial receipt of this Agreement and all other time periods required by applicable law, within which to consider this Release (it being understood by Executive that Executive may
execute this Release less than 21 days from its receipt from the Company, but agrees that such execution will represent his knowing waiver of such 21-day consideration period), and he has been advised by the Company to consult with counsel in
respect thereof; 
  

 2 

 (f) That he has seven (7) calendar days after signing this Release within which to
rescind the portion of this Release relating to Claims (as defined below) arising under the ADEA or any other federal, state, or local law that requires inclusion of such rescission right on any release of Claims arising under such laws, in writing
and delivered to the Company; 
 (g) That Executive shall not be entitled to any of the benefits specified in the Agreement if
Executive rescinds all or any portion of this Release; and 
 (h) That at no time prior to or contemporaneous with his
execution of this Release has he filed or caused or knowingly permitted the filing or maintenance, in any state, federal or foreign court, or before any local, state, federal or foreign administrative agency or other tribunal, any charge, claim or
action of any kind, nature and character whatsoever (“Claim”), known or unknown, suspected or unsuspected, which he may now have or has ever had against the Company Parties which is based in whole or in part on any matter referred
to in Section 1 above; and, subject to the Company’s performance under this Release, to the maximum extent permitted by law, Executive is prohibited from filing or maintaining, or causing or knowingly permitting the filing or maintaining,
of any such Claim in any such forum. Executive hereby grants the Company his perpetual and irrevocable power of attorney with full right, power and authority to take all actions necessary to dismiss or discharge any such Claim. Executive further
covenants and agrees that he will not encourage any person or entity, including but not limited to any current or former employee, officer, director or stockholder of the Company, to institute any Claim against the Company Parties or any of them,
and that except as expressly permitted by law or administrative policy or as required by legally enforceable order he will not aid or assist any such person or entity in prosecuting such Claim. 
 7. The Company (meaning, solely for this purpose, the Company’s directors and executive officers and other individuals authorized to make official
communications on the Company’s behalf) will not disparage Executive or Executive’s performance or otherwise take any action which could reasonably be expected to adversely affect Executive’s personal or professional reputation.
Similarly, Executive will not disparage the Company, any of its Subsidiaries or any of their respective directors and executives, officers and other individuals authorized to make official communications on the Company’s behalf or otherwise
take any action which could reasonably be expected to adversely affect the personal or professional reputation of the Company, its Subsidiaries or any of their respective directors, executive officers or other individuals authorized to make official
communications on the Company’s behalf. 
 8. This Release is mutual, and the Company hereby releases Executive from all claims and to
the same extent as described above in this Release, effective as of the seventh day following the date hereof, if Executive has not rescinded this Release in accordance with Section 6(f) hereof. Executive hereby represents and warrants to the
Company and each of the Company Parties that at no time prior to or contemporaneous with his execution of this Release has he knowingly engaged in any wrongful conduct against, on behalf of or as the representative or agent of the Company or any of
its Subsidiaries (as defined in the Agreement). 
  

 3 

 9. Miscellaneous 
 (a) This Release and the Agreement, and any other documents expressly referenced therein, constitute the complete and entire agreement and
understanding of Executive and the Company with respect to the subject matter hereof, and supersedes in its entirety any and all prior understandings, commitments, obligations and/or agreements, whether written or oral, with respect thereto; it
being understood and agreed that this Release and including the mutual covenants, agreements, acknowledgments and affirmations contained herein, is intended to constitute a complete settlement and resolution of all matters set forth in
Section 1 hereof. 
 (b) The Company Parties are intended third-party beneficiaries of this Release, and this Release may
be enforced by each of them in accordance with the terms hereof in respect of the rights granted to such Company Parties hereunder. Except and to the extent set forth in the preceding two sentences, this Release is not intended for the benefit of
any Person other than the parties hereto, and no such other person or entity shall be deemed to be a third party beneficiary hereof. Without limiting the generality of the foregoing, it is not the intention of the Company to establish any policy,
procedure, course of dealing or plan of general application for the benefit of or otherwise in respect of any other employee, officer, director or stockholder, irrespective of any similarity between any contract, agreement, commitment or
understanding between the Company and such other employee, officer, director or stockholder, on the one hand, and any contract, agreement, commitment or understanding between the Company and Executive, on the other hand, and irrespective of any
similarity in facts or circumstances involving such other employee, officer, director or stockholder, on the one hand, and Executive, on the other hand. 
 (c) The invalidity or unenforceability of any provision of this Release shall not affect the validity or enforceability of any other provision of this Release, which shall otherwise remain in full force and effect.

 (d) This Release may be executed in separate counterparts, each of which shall be deemed to be an original and all of which
taken together shall constitute one and the same agreement. 
 (e) The obligations of each of the Company and Executive
hereunder shall be binding upon their respective successors and assigns. The rights of each of the Company and Executive and the rights of the Company Parties shall inure to the benefit of, and be enforceable by, any of the Company’s,
Executive’s and the Company Parties’ respective successors and assigns. The Company may assign all rights and obligations of this Release to any successor in interest to the assets of the Company. 
 (f) No amendment to or waiver of this Release or any of its terms shall be binding upon any party hereto unless consented to in writing by
such party. 
 (g) ALL ISSUES AND QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS
RELEASE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICT OF LAW RULES OR PROVISIONS (WHETHER OF 

  

 4 

 
THE STATE OF DELAWARE OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE APPLICATION HERETO OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF DELAWARE.

 * * * * * 
  

 5 

 Intending to be legally bound hereby, Executive and the Company have executed this Release as of the date
first written above. 
  

			
	KEYSTONE AUTOMOTIVE HOLDINGS, INC.
		
	By:	 	  

	Name:	 	
	Title:	 	

 READ CAREFULLY BEFORE SIGNING 
 I have read this Release and have been given adequate opportunity, including 21 days from my initial receipt of this Release, to review this Release and to consult legal
counsel prior to my signing of this Release. I understand that by executing this Release I will relinquish certain rights or demands I may have against the Company Parties or any of them. 
  

	
	  

	[Executive]

  

	
	Witness:
	
	  

  

 6Exhibit 4.1

 Exhibit 4.1 
 PRICING INSTRUMENT 
 WHEREAS, the parties named herein desire to enter into certain Program Documents
(as defined herein) contained herein, each such document (unless otherwise specified in such document) dated as of the date of the Pricing Supplement (attached to this Pricing Instrument as Exhibit C) (the “Pricing Supplement”), relating
to the issuance by Genworth Global Funding Trust 2007-A (the “Trust”) of Notes to investors under the secured notes program sponsored by Genworth Life and Annuity Insurance Company (“GLAIC”); 
 WHEREAS, the Trust is a trust and will be organized under and its activities will be governed by the provisions of the Trust Agreement (set forth in
Section A of this Pricing Instrument), dated as of the date of the Pricing Supplement, by and between the parties thereto indicated in Section E herein; 
 WHEREAS, certain expense and indemnification arrangements between GLAIC and the Trustee, on behalf of itself and on behalf of the Trust, are governed pursuant to the provisions of the Expense and Indemnity Agreement
dated as of October 1, 2006 by and between GLAIC and the Trustee; 
 WHEREAS, certain licensing arrangements between the Trust and
Genworth Financial, Inc. will be governed pursuant to the provisions of the License Agreement dated as of October 28, 2005, by and between the Trust and Genworth Financial, Inc.; 
 WHEREAS, certain custodial arrangements for the Funding Agreement will be governed pursuant to the provisions of the Custodial Agreement (the
“Custodial Agreement”) dated as of December 7, 2005 by and among SunTrust Bank, acting as custodian (the “Custodian”), the Indenture Trustee and the Trust; 
 WHEREAS, the Notes will be issued pursuant to the Indenture (set forth in Section B of this Pricing Instrument), dated as of the Original Issue Date, by
and between the parties thereto indicated in Section E herein; 
 WHEREAS, the sale of the Notes will be governed by the Terms Agreement (set
forth in Section C of this Pricing Instrument), dated as of the date of the Pricing Supplement, by and among the parties thereto indicated in Section E herein; and 
 WHEREAS, certain agreements relating to the Notes and the Funding Agreement are set forth in the Coordination Agreement (set forth in Section D of this Pricing Instrument), dated as of the date of the Pricing
Supplement, by and among the parties thereto indicated in Section E herein. 
 All capitalized terms used herein and not otherwise defined
will have the meanings set forth in the Indenture. 
  

 1 

 SECTION A 
 TRUST AGREEMENT 
 This TRUST AGREEMENT (this “Trust Agreement”), dated as of the date of the
Pricing Supplement, is entered into by and between GSS Holdings II, Inc., a Delaware corporation, as trust beneficial owner (the “Trust Beneficial Owner”), and U.S. Bank National Association, a national banking association, as Trustee (the
“Trustee”). 
 References in the Standard Trust Terms to JPMorgan Chase Bank, N.A. shall refer to The Bank of New York
Trust Company, N.A. and its permitted successors and assigns. 
 WITNESSETH: 
 WHEREAS, the Trust Beneficial Owner and the Trustee desire to authorize the issuance of a Trust Beneficial Interest and a series of Notes in connection
with the entry into this Trust Agreement; 
 WHEREAS, all things necessary to make this Trust Agreement a valid and legally binding agreement
of the Trustee and the Trust Beneficial Owner, enforceable in accordance with its terms, have been done; 
 WHEREAS, the parties intend to
provide for, among other things, (i) the issuance and sale of the Notes (pursuant to the Indenture, the Distribution Agreement and the related Terms Agreement) and the Trust Beneficial Interest, (ii) the use of the proceeds of the sale of
the Notes and Trust Beneficial Interest to acquire the Funding Agreement, and (iii) all other actions deemed necessary or desirable in connection with the transactions contemplated by this Trust Agreement; and 
 WHEREAS, the parties hereto desire to incorporate by reference those certain Standard Trust Terms, dated as of December 8, 2005, and attached to the
Pricing Instrument as Exhibit A (the “Standard Trust Terms”). 
 NOW, THEREFORE, in consideration of the agreements and
obligations set forth herein and for other good and valuable consideration, the sufficiency of which are hereby acknowledged, each party hereby agrees as follows: 
 ARTICLE 1 
 Section 1.01 Incorporation by Reference. All terms, provisions and agreements set
forth in the Standard Trust Terms (except to the extent expressly modified herein) are hereby incorporated herein by reference with the same force and effect as though fully set forth herein. All capitalized terms not otherwise defined herein
(including the recitals hereof) shall have the meanings set forth in the Standard Trust Terms (the Standard Trust Terms and this Trust Agreement, collectively, the “Trust Agreement”). To the extent that the terms set forth in Article 2 of
this Trust Agreement are inconsistent with the terms of the Standard Trust Terms, the terms set forth in Article 2 herein shall apply. 
  

 A-1 

 ARTICLE 2 
 Section 2.01 Name. The Trust created and governed by this Trust Agreement shall be the trust specified in the Pricing Instrument. The name of the Trust shall be the name specified in the first paragraph of
the Pricing Instrument, as such name may be modified from time to time by the Trustee following written notice to the Trust Beneficial Owner. 
 Section 2.02 Jurisdiction. The Trust is hereby organized in, and formed under and pursuant to, the laws of the jurisdiction specified in the Pricing Supplement. 
 Section 2.03 Initial Capital Contribution and Ownership. The Trust Beneficial Owner has paid or has caused to be paid to, or to an account at
the direction of, the Trustee, on the date hereof, the sum of $15 (or, in the case of Notes issued with original issue discount, such amount multiplied by the issue price of the Notes as specified in the Pricing Supplement). The Trustee hereby
acknowledges receipt in trust from the Trust Beneficial Owner, as of the date hereof, of the foregoing contribution, which shall be used along with the proceeds from the sale of the series of Notes to purchase the Funding Agreement. Upon the
creation of the Trust and the registration of the Trust Beneficial Interest in the Securities Register (as defined in the Trust Agreement) by the Trust Registrar in the name of the Trust Beneficial Owner, the Trust Beneficial Owner shall be the sole
beneficial owner of the Trust. 
 Section 2.04 Acknowledgment. The Trustee, on behalf of the Trust, expressly acknowledges its
duties and obligations set forth in the Standard Trust Terms incorporated herein by reference. 
 Section 2.05 Additional Terms.
Section 5.01(a) of the Standard Trust Terms is hereby replaced with the following: “it is a national banking association duly organized, validly existing and in good standing under the laws of the United States of America and it is a
“bank” within the meaning of Section 581 of the Code;”. 
 Section 2.06 Pricing Instrument; Execution and
Incorporation of Terms. 
 The parties hereto will enter into the Trust Agreement by executing the Pricing Instrument. 
 By executing the Pricing Instrument, the Trustee and the Trust Beneficial Owner hereby agree that the Trust Agreement will constitute a legal, valid and
binding agreement between the Trustee and the Trust Beneficial Owner. 
 All terms relating to the Trust or the series of Notes not otherwise
included herein will be as specified in the Pricing Instrument or Pricing Supplement, as indicated herein. 
 Section 2.07 Governing
Law. This Trust Agreement will be governed by, and construed in accordance with, the laws of the jurisdiction specified in the Pricing Supplement. 
  

 A-2 

 Section 2.08 Counterparts. The Trust Agreement, through the Pricing Instrument, may be
executed in any number of counterparts, each of which counterparts shall be deemed to be an original, and all of which counterparts shall constitute but one and the same instrument. 
  

 A-3 

 SECTION B 
 INDENTURE 
 This INDENTURE (this “Indenture”) is entered into as of the Original Issue Date by and
between the Genworth Global Funding Trust specified in the Pricing Instrument (the “Trust”) and The Bank of New York Trust Company, N.A., as the indenture trustee (the “Indenture Trustee”). 
 The Bank of New York Trust Company, N.A., in its capacity as Indenture Trustee, hereby accepts its role as Registrar, Paying Agent, Transfer Agent and
Calculation Agent hereunder. 
 References herein to “Indenture Trustee,” “Registrar,” “Transfer Agent,”
“Paying Agent” or “Calculation Agent” shall include the permitted successors and assigns of any such entity from time to time and references in the Standard Indenture Terms to The Bank of New York shall refer to U.S. Bank
National Association and its permitted successors and assigns. 
 WITNESSETH: 
 WHEREAS, the Trust has duly authorized the execution and delivery of this Indenture to provide for the issuance of Notes; 
 WHEREAS, all things necessary to make this Indenture a valid and legally binding agreement of the Trust and the other parties to this Indenture,
enforceable in accordance with its terms, have been done, and the Trust proposes to do all things necessary to make the Notes, when executed by the Trust and authenticated and delivered pursuant hereto, valid and legally binding obligations of the
Trust as hereinafter provided; and 
 WHEREAS, the parties hereto desire to incorporate by reference those certain Standard Indenture Terms,
dated as of December 8, 2005, and attached to the Pricing Instrument as Exhibit B (the “Standard Indenture Terms”). 
 NOW, THEREFORE, for and in consideration of the premises and the purchase of the Notes by the Holders thereof, it is mutually covenanted and agreed by each of the parties hereto as follows: 
 ARTICLE 1 
 Section 1.01
Incorporation by Reference. All terms, provisions and agreements set forth in the Standard Indenture Terms (except to the extent expressly modified herein) are hereby incorporated herein by reference with the same force and effect as though
fully set forth herein. All capitalized terms not otherwise defined herein (including the recitals hereof) shall have the meanings set forth in the Standard Indenture Terms (the Standard Indenture Terms and this Indenture, collectively, the
“Indenture”). To the extent that the terms set forth in Article 2 of this Indenture are inconsistent with the terms of the Standard Indenture Terms, the terms set forth in Article 2 herein shall apply. 
  

 B-1 

 ARTICLE 2 
 Section 2.01 Agreement to be Bound. Each of the Trust, the Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent and the Calculation Agent hereby agrees to be bound by all of the terms,
provisions and agreements set forth in the Indenture, with respect to all matters contemplated in the Indenture, including, without limitation, those relating to the issuance of the below-referenced Notes. 
 Section 2.02 Designation of the Trust, the Notes and the Funding Agreement. The Trust created by the Trust Agreement specified in the Pricing
Instrument and referred to herein is the Genworth Global Funding Trust specified in the Pricing Instrument. The Notes issued by the Trust and governed by the Indenture shall be the Notes specified in the Pricing Supplement. The Funding Agreement
designated hereby is the Funding Agreement designated in the Pricing Supplement, effective as of the Original Issue Date, between the Trust and Genworth Life and Annuity Insurance Company. 
 Section 2.03 Additional Terms. 
 None. 
 Section 2.04 Pricing Instrument; Execution and Incorporation of Terms. 
 The parties hereto will enter into this Indenture by executing the Pricing Instrument. 
 By executing the Pricing Instrument, the Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent, the Calculation Agent and the Trust
hereby agree that the Indenture will constitute a legal, valid and binding agreement between the Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent, the Calculation Agent and the Trust. 
 All terms relating to the Trust or the Notes not otherwise included herein will be as specified in the Pricing Instrument or Pricing Supplement, as
indicated herein. 
 Section 2.05 Counterparts. This Indenture, through the Pricing Instrument, may be executed in any number of
counterparts, each of which counterparts shall be deemed to be an original, and all of which counterparts shall constitute one and the same instrument. 
 [Remainder of Page Left Intentionally Blank] 
  

 B-2 

 SECTION C 
 TERMS AGREEMENT 
 This TERMS AGREEMENT (this “Terms Agreement”) is entered into as of the date of
the Pricing Supplement by and among Genworth Life and Annuity Insurance Company (“GLAIC”), the Genworth Global Funding Trust specified in the Pricing Instrument (the “Trust”) and the Agents specified in the Pricing Supplement
(the “Agents”). 
 WITNESSETH: 
 WHEREAS, GLAIC and the Agents have entered into that certain Distribution Agreement dated December 9, 2005 (the “Distribution Agreement”). 
 NOW, THEREFORE, in consideration of the mutual promises set forth herein and other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, each of the parties hereby agrees as
follows: 
 ARTICLE 1 
 Section 1.01 Incorporation by Reference. The provisions of the Distribution Agreement and the related definitions (unless otherwise specified herein) are incorporated by reference herein and shall be deemed to have the same
force and effect as if set forth in full herein. 
 ARTICLE 2 
 Section 2.01 Addition of Trust as Party to Distribution Agreement. 
 Pursuant to Section 1
of the Distribution Agreement, each of the undersigned parties hereby acknowledges and agrees that the Trust, upon execution hereof by the Trust and the other parties to this Terms Agreement, shall become a Trust for purposes of the Distribution
Agreement in accordance with the terms thereof, in respect of the Notes, with all the authority, rights, powers, duties and obligations of a Trust under the Distribution Agreement. The Trust confirms that any agreement, covenant, acknowledgment,
representation or warranty under the Distribution Agreement applicable to the Trust is made by the Trust at the date hereof, unless another time or times are specified in the Distribution Agreement, in which case such agreement, covenant,
acknowledgment, representation or warranty shall be deemed to be confirmed by the Trust at such specified time or times. 
 All references to
Section 9 (Indemnification) of the Distribution Agreement to “solely with respect to the applicable Agent(s) or Co-Agent(s)” will include all of such Agent’s or Co-Agent’s directors and officers and each person, if any, who
controls such Agent or Co-Agent within the meaning of Section 15 of the Securities Act of 1933, as amended or Section 20 of the Securities Exchange Act of 1934, as amended. All references in the Distribution Agreement to the
“Registration Statement”, the “Institutional Base Prospectus”, the “Retail Base Prospectus”, any “preliminary prospectus”, the “Time of Sale Prospectus” and the “Prospectus” shall also be
deemed to include all documents incorporated by reference therein. 
  

 C-1 

 Section 2.02 Purchase of Notes as Principal. 
 (a) Subject in all respects to the terms and conditions of the Distribution Agreement, the Trust hereby agrees to sell to the Agent and the Agent hereby
agrees to purchase, severally and not jointly, the Notes having the terms specified in the Pricing Supplement relating to such Notes. 
 (b)
In connection with any purchase of Notes from the Trust by the Agent as principal, the parties agree that the items specified on Schedule I of the Pricing Instrument will be delivered as of the Settlement Date. 
 Section 2.03 Termination. Upon the termination of this Terms Agreement pursuant to Section 13(b) of the Distribution Agreement the
undersigned parties hereby agree to allocate the expenses reasonably incurred prior to or in connection with such termination as follows: 
 The expenses will be borne by GLAIC. 
 Section 2.04 Applicable Time. For purposes of the Distribution Agreement, the
Applicable Time shall be 12:55 pm EST, April 17, 2007. 
 Section 2.05 Governing Law. This Terms Agreement shall be governed
by and construed in accordance with the laws of the State of New York without regard to the principles of conflicts of laws thereof. 
 Section 2.06 Notices. For purposes of Section 14 of the Distribution Agreement, the Trust’s communications details are as set forth in Section D of the Pricing Instrument. 
 Section 2.07 Additional Terms. The Agent represents, warrants and covenants with or to (as the case may be) the Trust and the Company that it
has not offered, sold or delivered and it will not offer, sell or deliver, any of the Notes, in or from any jurisdiction except under circumstances that are reasonably designed to result in compliance with the applicable securities laws and
regulations thereof. 
 Section 2.08 Pricing Instrument; Execution and Incorporation of Terms. 
 The parties hereto will enter into this Terms Agreement by executing the Pricing Instrument. 
 By executing the Pricing Instrument, each party hereto agrees that this Terms Agreement will constitute a legal, valid and binding agreement by and among
such parties. 
 All terms relating to the Trust or the Notes not otherwise included in this Terms Agreement will be as specified in the
Pricing Instrument or Pricing Supplement, as indicated herein. 
 Section 2.09 Counterparts. This Terms Agreement, through the
Pricing Instrument, may be executed in any number of counterparts, each of which counterparts shall be deemed to be an original, and all of which counterparts shall constitute but one and the same instrument. 
  

 C-2 

 EXHIBIT A 
  

 C-3 

 SECTION D 
 COORDINATION AGREEMENT 
 This COORDINATION AGREEMENT (this “Coordination Agreement”), dated as of
the date of the Pricing Supplement, is entered into by and among Genworth Life and Annuity Insurance Company (“GLAIC”), the Genworth Global Funding Trust specified in the Pricing Instrument (the “Trust”), SunTrust Bank, in its
capacity as custodian of the Funding Agreement (“Custodian”) and The Bank of New York Trust Company, N.A., as the indenture trustee (the “Indenture Trustee”). 
 W I T N E S S E T H 
 WHEREAS, the Trust will enter into the Funding Agreement with
GLAIC, effective as of the Original Issue Date specified in the Pricing Supplement; 
 WHEREAS, the Agent (as defined in the Distribution
Agreement) will sell the Notes in accordance with the Registration Statement; 
 WHEREAS, the Trust intends to issue the Notes in accordance
with the Indenture, to collaterally assign to, and grant a security interest in, the Funding Agreement to and in favor of the Indenture Trustee in accordance with the Indenture to secure payment of the Notes; and 
 WHEREAS, the Custodian will hold the Funding Agreement on behalf of the Indenture Trustee pursuant to the terms of the Custodial Agreement. 

NOW, THEREFORE, to give effect to the agreements and arrangements established under the Terms Agreement included in the Pricing Instrument, as
applicable, the Trust Agreement, the Indenture and the Notes, and in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the sufficiency of which are hereby acknowledged, each party hereby
agrees as follows: 
 ARTICLE 1 
 Section 1.01 Delivery of the Funding Agreement. The Trust hereby authorizes the Custodian, on behalf of the Indenture Trustee, to receive the Funding Agreement from GLAIC pursuant to the assignment of the Funding Agreement (the
“Assignment”), to be entered into on the Original Issue Date, included in the closing instrument dated as of the Original Issue Date (the “Closing Instrument”). 
 Section 1.02 Issuance and Purchase of the Notes. 
 (a) Delivery of the Funding Agreement to the Custodian, on behalf of the Indenture Trustee, pursuant to the Assignment or execution of the cross-receipt contained in the Closing Instrument shall be confirmation of
payment by the Trust for the Funding Agreement. 
 (b) The Trust hereby directs the Indenture Trustee, upon receipt of the Funding Agreement
by the Custodian, on behalf of the Indenture Trustee and pursuant to the Assignment, (i) to authenticate the certificates representing the Notes (the “Certificates”) 

  

 D-1 

 
in accordance with the Indenture and (ii) to (A) deliver each relevant Certificate to the clearing system or systems identified in each such
Certificate, or to the nominee of such clearing system, or the custodian thereof, for credit to such accounts as the Agent may direct, or (B) deliver each relevant Certificate to the purchasers thereof as identified by the Agent. 
 ARTICLE 2 
 Section 2.01 Directions
Regarding Periodic Payments. As registered owner of the Funding Agreement as collateral securing payments on the Notes, the Indenture Trustee will receive payments on the Funding Agreement on behalf of the Trust. The Trust hereby directs the
Indenture Trustee to use such funds to make payments on behalf of the Trust pursuant to the Trust Agreement and the Indenture. 
 Section 2.02 Maturity of the Funding Agreement. Upon the maturity of the Funding Agreement and the return of funds thereunder, the Trust hereby directs the Indenture Trustee to set aside from such funds an amount sufficient for
the repayment of the outstanding principal on the Notes and Trust Beneficial Interest when due. 
 ARTICLE 3 
 Section 3.01 Officer’s Certificates. GLAIC hereby agrees to deliver an Officer’s Certificate, a copy of which is attached hereto as
Exhibit D, on a quarterly basis to any rating agency currently rating the Program. The Trust hereby agrees to deliver an Officer’s Certificate, a copy of which is attached to the Pricing Instrument as Exhibit E, on a quarterly
basis to any rating agency currently rating the Program. 
 Section 3.02 Filings. GLAIC hereby covenants to file, or cause to be
filed, in a timely manner on behalf of the Trust all reports, certifications or similar filings required under the Securities Exchange Act of 1934, as amended. 
 ARTICLE 4 
 Section 4.01 No Additional Liability. Nothing in this Coordination Agreement shall
impose any liability or obligation on the part of any party to this Coordination Agreement to make any payment or disbursement in addition to any liability or obligation such party has under the Program Documents, except to the extent that a party
has actually received funds which it is obligated to disburse pursuant to this Coordination Agreement. 
 Section 4.02 No
Conflict. This Coordination Agreement is intended to be in furtherance of the agreements reflected in the documents related to the Program Documents, and not in conflict. To the extent that a provision of this Coordination Agreement conflicts
with the provisions of one or more Program Documents, the provisions of such Program Documents shall govern. 
 Section 4.03
Governing Law. This Coordination Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to the principles of conflicts of laws thereof. 
  

 D-2 

 Section 4.04 Severability. If any provision in this Coordination Agreement shall be invalid,
illegal or unenforceable, such provision shall be deemed severable from the remaining provisions of this Coordination Agreement and shall in no way affect the validity or enforceability of such other provisions of this Coordination Agreement.

 Section 4.05 Notices. All demands, notices and communications under this Coordination Agreement shall be in writing and shall
be deemed to have been duly given upon receipt at the addresses set forth below: 
 To the Trust: 
 Genworth Global Funding Trust 2007-A 
 c/o U.S. Bank National Association 
 Corporate Trust Services 
 209 S. LaSalle Street, Suite 300 
 Chicago, Illinois 60604 
 Attention: Patricia Child, VP 
 Facsimile: (312) 325-8905 
 To the Indenture Trustee: 
 The Bank of New York Trust Company, N.A. 
 2 North LaSalle Street, Suite 1020 
 Chicago, Illinois 60602 
 Attention: Corporate Finance 
 Facsimile: (312) 827-8542 
 To GLAIC: 
 Genworth Life and Annuity Insurance Company 
 6610 West Broad Street 
 Richmond, Virginia 23230 
 Attention: Treasurer 
 Facsimile: (804) 662-7777 
 with a copy to: 
 Genworth Life and Annuity Insurance Company 
 6610 West Broad Street 
 Richmond, Virginia 23230 
 Attention: Heather Harker, Esq. 
 Facsimile: (804) 281-6005 
 To the Custodian: 
 SunTrust Bank 
 919 East Main Street 
 Richmond, Virginia 23219 
 Attention: Retirement Services 
 Facsimile: (804) 782-7439 
  

 D-3 

 or at such other address as shall be designated by any such party in a written notice to the other parties. 

ARTICLE 5 
 Section 5.01 Pricing
Instrument; Execution and Incorporation of Terms. 
 The parties to this Coordination Agreement will enter into this Coordination
Agreement by executing the Pricing Instrument. 
 By executing the Pricing Instrument, each party hereto agrees that this Coordination
Agreement will constitute a legal, valid and binding agreement by and among the Trust, GLAIC, the Custodian and the Indenture Trustee. 
 All
terms relating to the Trust or the Notes not otherwise included in this Coordination Agreement will be as specified in the Pricing Instrument or Pricing Supplement, as indicated herein. 
 Section 5.02 Counterparts. This Coordination Agreement, through the Pricing Instrument, may be executed in any number of counterparts, each
of which counterparts shall be deemed to be an original, and all of which counterparts shall constitute but one and the same instrument. 
 Section 5.03 Capitalized Terms. All capitalized terms used herein and not otherwise defined in this Coordination Agreement will have the meanings set forth in the Indenture. 
 [Remainder of Page Left Intentionally Blank] 
  

 D-4 

 SECTION E 
 MISCELLANEOUS AND EXECUTION PAGES 
 This Pricing Instrument may be executed by each of the parties hereto in
any number of counterparts, and by each of the parties hereto on separate counterparts, each of which counterparts, when so executed and delivered, shall be deemed to be an original, but all such counterparts shall together constitute but one and
the same instrument. 
 Each signatory, by its execution hereof, does hereby become a party to each of the agreements or indenture identified
for such party as of the date specified in such agreements or indenture. 
 IN WITNESS WHEREOF, the undersigned have executed this Pricing
Instrument with respect to the Notes as of the date first written above. 
  

			
	GENWORTH LIFE AND ANNUITY INSURANCE
COMPANY (in executing below agrees and becomes
a party to (i) the Terms Agreement set forth in
Section C herein and (ii) the
Coordination Agreement
set forth in Section D herein)
		
	By:	 	 /s/ Pamela C. Asbury

	Name:	 	Pamela C. Asbury
	Title:	 	Vice President

 [Execution Page 1 of 3] 
  

 E-1 

			
	THE GENWORTH GLOBAL FUNDING TRUST DESIGNATED IN THIS PRICING INSTRUMENT (in executing below agrees and becomes a party to (i) the Indenture set forth in Section B herein, (ii) the
Terms Agreement set forth in Section C herein and (iii) the Coordination Agreement set forth in Section D herein)
		
	By:	 	U.S. BANK NATIONAL ASSOCIATION, not in its individual capacity but solely in its capacity as Trustee of the Trust
		
	By:	 	 /s/ Patricia M. Child

	Name:	 	Patricia M. Child
	Title:	 	Vice President
	
	U.S. BANK NATIONAL ASSOCIATION (in executing below agrees and becomes a party to the Trust Agreement set forth in Section A herein), as Trustee
		
	By:	 	 /s/ Patricia M. Child

	Name:	 	Patricia M. Child
	Title:	 	Vice President
	
	U.S. BANK NATIONAL ASSOCIATION (in executing below acknowledges and agrees to Section 5.01 of the Trust Agreement as set forth in and amended by Section A herein), in its
individual capacity
		
	By:	 	 /s/ Patricia M. Child

	Name:	 	Patricia M. Child
	Title:	 	Vice President
	
	GSS HOLDINGS II, INC. (in executing below agrees and becomes a party to the Trust Agreement set forth in Section A herein), as Trust Beneficial Owner
		
	By:	 	 /s/ Andrew L. Stidd

	Name:	 	Andrew L. Stidd
	Title:	 	Vice President

 [Execution Page 2 of 3] 
  

 E-2 

			
	THE BANK OF NEW YORK TRUST COMPANY, N.A. (in executing below agrees and becomes a party to (i) the Indenture set forth in Section B herein, as Indenture Trustee, Registrar, Transfer
Agent, Paying Agent and Calculation Agent and (ii) the Coordination Agreement set forth in Section D herein), as Indenture Trustee, Registrar, Transfer Agent, Paying Agent and Calculation Agent
		
	By:	 	 /s/ R. Tarnas

	Name:	 	R. Tarnas
	Title:	 	Vice President
	
	SUNTRUST BANK (in executing below agrees and becomes a party to the Coordination Agreement set forth in Section D herein), as Custodian
		
	By:	 	 /s/ Richard J. Owens

	Name:	 	Richard J. Owens
	Title:	 	AVP/Trust Officer
	
	BANC OF AMERICA SECURITIES LLC (in executing below agrees and becomes a party to the Terms Agreement set forth in Section C herein)
		
	By:	 	 /s/ Lily Chang

	Name:	 	Lily Chang
	Title:	 	Principal

 [Execution Page 3 of 3] 
  

 E-3 

 EXHIBIT A 
 Standard Trust Terms 
 As filed as Exhibit 4.5 to the Registration Statement on Form S-3 (File No. 333-128718), filed
by Genworth Life and Annuity Insurance Company with the Securities and Exchange Commission (the “Commission”) on September 30, 2005, as amended by Amendment No. 1, filed with the Commission on December 8, 2005. 

 

 A-1 

 EXHIBIT B 
 Standard Indenture Terms 
 As filed as Exhibit 4.1 to the Registration Statement on Form S-3 (File No. 333-128718),
filed by Genworth Life and Annuity Insurance Company with the Securities and Exchange Commission (the “Commission”) on September 30, 2005, as amended by Amendment No. 1, filed with the Commission on December 8, 2005.

  

 B-1 

 EXHIBIT C 
 Pricing Supplement 
 As filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act,
dated as of April 17, 2007, with respect to the Notes to be issued by the Trust. 
  

 C-1 

 EXHIBIT D 
 Genworth Life and Annuity Insurance Company 
 Officer’s Certificate 
 The undersigned, an officer of Genworth Life and Annuity Insurance Company, a stock life insurance company operating under a charter granted by the
Commonwealth of Virginia (“GLAIC”), does hereby certify to Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc., in such capacity and on behalf of GLAIC, to the knowledge of the undersigned and
after reasonable inquiry, that: 
  

	 	1.	each of the representations and warranties of GLAIC contained in each Expense and Indemnity Agreement entered into in connection with the Registration Statement (defined below), and
each Funding Agreement issued in connection with the Program (the “Specified Agreements”) (other than any representation or warranty expressly made as of a date prior to the date hereof) are true and correct on and as of the date hereof,
with the same effect as though such representation or warranty had been made on and as of the date hereof; 

  

	 	2.	no default under any of the Specified Agreements and no event or any condition which, with notice or lapse of time or both, would become a default, has occurred and is continuing as
of the date hereof; 

  

	 	3.	GLAIC has performed and complied with, in all material respects, all of the agreements, covenants, obligations and conditions applicable to GLAIC required by the Specified
Agreements to be performed or complied with by GLAIC on or before the date hereof; 

  

	 	4.	the Registration Statement filed on Form S-3 (File No. 333-128718) (the “Registration Statement”) by GLAIC has been declared effective by the Securities and Exchange
Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”) and no stop order suspending the effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been
commenced by or are pending before or contemplated by the Commission; 

  

	 	5.	all filings, if any, required by Rule 424 and Rule 430A under the Act have been made in a timely manner; 

  

	 	 6.
	 since [·]1, the Trusts organized in connection with the program contemplated by the Registration Statement have
issued the following series of Notes: 

 [List each series of Notes] [(collectively, the “Designated Notes”)]; and

  

	 	7.	the Funding Agreements issued in connection with the Designated Notes have been executed and delivered by GLAIC in accordance with the terms and conditions of the Program Documents.

	 1
	 This certificate to be signed quarterly. 

  

 D-1 

 Capitalized terms used herein and not otherwise defined herein shall have the meanings set forth in the
Standard Indenture Terms attached as Exhibit 4.1 to the Registration Statement. 
 IN WITNESS WHEREOF, the undersigned has executed this
Certificate as of the [·] day of [·]
200[·]. 
  

			
	[Name], in [his/her] capacity as an authorized officer of Genworth Life and Annuity Insurance Company
		
	By:	 	  

	Name:	 	
	Title:	 	

  

 D-2 

 EXHIBIT E 
 Genworth Global Funding Trusts 
 Trustee Officer’s Certificate 
 U.S. Bank National Association, not in its individual capacity but solely in its capacity as trustee acting on behalf of each common law trust organized
under the laws of the State of Illinois (in such capacity, the “Trustee,” and each such common law trust being referred to herein as a “Trust”) in connection with the program contemplated by the Registration Statement filed on
Form S-3 (File No. 333-128718) by Genworth Life and Annuity Insurance Company with the Securities and Exchange Commission (the “Commission”) on September 30, 2005, as amended by Amendment No. 1, filed with the Commission on
December 8, 2005 (the “Registration Statement”), does hereby certify to Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc., in such capacity and on behalf of each Trust, to the knowledge of
the Trustee without any independent investigation, that; as of October 1, 2006: 
  

	 	1.	each of the representations and warranties of each Trust contained in the Notes issued in connection with the Program, each Indenture entered into in connection with the
Registration Statement and the Expense and Indemnity Agreement concerning the Trusts (the “Specified Agreements”) (other than any representation or warranty expressly made as of a date prior to the date hereof) are true and correct on and
as of the date hereof, with the same effect as though such representation or warranty had been made on and as of the date hereof; 

  

	 	2.	no default under any of the Specified Agreements and no event or any condition which, with notice or lapse of time or both, would become a default, has occurred and is continuing as
of the date hereof; 

  

	 	3.	each Trust has performed and complied with, in all material respects, all of the agreements, covenants, obligations and conditions applicable to such Trust required by the Specified
Agreements to be performed or complied with by such Trust on or before the date hereof; 

  

	 	4.	the Notes issued in connection with the Program have been issued, in all material respects, in accordance with the terms and conditions of the Program Documents; and

  

	 	5.	each Funding Agreement has been executed and delivered by the related Trust in accordance with the terms and conditions of the Program Documents. 

 Capitalized terms used herein and not otherwise defined herein shall have the meanings set forth in the Standard Indenture Terms attached as Exhibit 4.1
to the Registration Statement. In no event shall U.S. Bank National Association in its personal corporate capacity (or any officer of the Trustee in his or her personal capacity) have any liability for any of the certifications or statements
contained in this Trustee Officer’s Certificate, such liability being solely that of each Trust. 
  

 E-1 

 IN WITNESS WHEREOF, the undersigned has executed this Certificate as of the [·] day of [·], 200[·]. 
  

			
	 U.S. Bank National Association, not in its individual
 capacity but solely in its capacity as Trustee acting on
 behalf of each Trust

		
	 By:
	 	  

	Name:	 	
	Title:	 	

  

 E-2 

 SCHEDULE I 
 Terms Agreement Specifications 
 In connection with Section 3(a)(iv) of the Distribution Agreement, the Program under
which the Notes are issued is rated Aa3 by Moody’s Investors Service, Inc. (“Moody’s”) and AA- by Standard & Poor’s Rating Services, a division of The McGraw-Hill Companies, Inc. (“S&P”). Genworth Life
and Annuity Insurance Company (“GLAIC”) expects that the Notes will be rated Aa3 by Moody’s and AA- by S&P. GLAIC’s financial strength rating is Aa3 by Moody’s and AA- by S&P. 
 In accordance with Section 2.02(b) of the Terms Agreement and in connection with the purchase of Notes from the Trust by the Agent as principal, the following items
will be delivered on or prior to the Settlement Date: 
  

	1)	Opinion of Emmet, Marvin & Martin LLP, counsel for the Indenture Trustee; and 

  

	2)	Opinion of Chapman & Cutler, LLP, counsel for the Trustee. 

 All capitalized terms used herein and not otherwise defined herein will have the meanings set forth in the Distribution Agreement. 
  

 I-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}]]